Physician profile
Charles Peter Capito
NPI 1770574212
$2,935.42
in general payments reported to CMS, 2019-2025
14 companies · $325 in 2025
The $325 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $597 · 2020: $203 · 2021: $503 · 2022: $101 · 2023: $232 · 2024: $974 · 2025: $325.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $947 · Travel and Lodging: $585.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $946.89 |
| Travel and Lodging | $584.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mid-Atlantic Surgical Systems, LLC | $584.67 | 2024 | |
| Stryker Corporation | $560.71 | 2019-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Inari Medical, INC. | $389.49 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Linvatec Corporation | $298.03 | 2019 | |
| Medtronic, INC. | $266.95 | 2023-2025 | Hawkone, Abre |
| Pacira Therapeutics, INC. | $188.13 | 2019-2021 | |
| Horizon Therapeutics Plc | $160.85 | 2019-2022 | |
| Pacira Pharmaceuticals Incorporated | $149.79 | 2021-2023 | Iovera, Zilretta |
| Amgen INC. | $118.00 | 2022-2023 | Evenity |
| Medtronic USA, INC. | $114.44 | 2020 | |
| Bioventus LLC | $58.89 | 2019-2021 | |
| Smith+Nephew, INC. | $19.26 | 2022 | |
| Depuy Synthes Sales INC. | $13.33 | 2021 | |
| Sonex Health, INC. | $12.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Capito listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.